The advances in melanoma staging and treatment

The advances in melanoma staging and treatment

Julie Scott, DNP
Julie Scott, DNP

Melanoma Staging

Once a diagnosis of melanoma has been made, the oncologist may order imaging studies to see if melanoma has spread to other areas of the body. Melanoma is staged from stage 0 to IV, with melanoma becoming more advanced the higher the stage. 

When the biopsy has resulted with melanoma, and staging studies have been completed, the oncologist can develop a treatment plan. 

Melanoma Treatment

Surgery is often used as a treatment for melanoma, with the type of surgery being a wide local excision (WLE). During this type of surgery, the entire melanoma lesion along with a wide amount of healthy tissue surrounding it is taken out, to be sure the entire melanoma has been removed. The full amount of tissue that needs to be removed depends upon the size and thickness of the melanoma lesion. 

Along with a WLE, a sentinel lymph node biopsy is often done. This surgery identifies the first lymph node closest to the melanoma using a special dye. This helps the surgeon identify it and remove the lymph node for evaluation of the presence of cancer cells. 

In addition to surgery, other treatments may be recommended based on the stage of the cancer. A commonly used treatment is immunotherapy. Immunotherapy medications are usually intravenous medications that work by helping the immune system see any melanoma cells in the body. This allows the immune system to help fight against melanoma. Examples of immunotherapy include:

  • Yervoy
  • Opdivo
  • Keytruda

Targeted treatment

Targeted treatment for BRAF mutations is available as well. Some people may benefit from the use of these after surgery, to help reduce the risk of melanoma returning. These medications work by interfering with the BRAF pathway melanoma cells use to grow. Examples of BRAF targeted therapy include a medication called dabrafenib. 

Early stage melanoma and Standard chemotherapy

Standard chemotherapy and radiation are rarely used for early stage melanoma. 

 

Julie Scott, DNP
Julie Scott, DNP
Julie is an oncology certified Oncology Nurse Practitioner with over a decade of medical oncology experience. In addition to her clinical work, she is an accomplished healthcare writer providing oncology content for various publications. She also serves as an adjunct faculty member for a Master's nursing program and a chair for Doctoral nursing students.

Download our
mobile app

Share this post
You may also like
Articles
Preserving fertility before undergoing cancer treatment
March 1, 2023

Cancer treatment can significantly impact a person's fertility, of both sexes, particularly for young patients.  However, there are options available for those who wish to preserve their fertility before undergoing cancer treatment. Cancer treatments, such as chemotherapy, radiation therapy, and surgery, can damage the reproductive organs and potentially affect a…

Julie Scott, DNP

author

Articles
The basics of Cutaneous T cell lymphoma: what it is and how it affects people
December 22, 2022

Cutaneous T cell lymphoma (CTCL) is a type of non-Hodgkin's lymphoma, cancer that grows in the lymphatic system. More specifically, CTCL grows in the T cells, a type of white blood cell that helps to fight infection. With CTCL, these T-cells become cancerous and cause the skin to develop lesions.…

Julie Scott, DNP

author

Articles
Melanoma
November 8, 2022

What is Melanoma? Melanoma is a cancer of the melanocytes, the pigment producing cells in the skin. Melanocytes can also be found in other areas outside of the skin, such as the eyes, genitals, and mouth, but melanoma most commonly develops in the skin.  Risk Factors The rates of melanoma…

Julie Scott, DNP

author

cancerGO gives you access to a community

Where are people to listen, answer questions, share information, and offer valuable and timely advice